Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
T. Rowe Price Group is a prominent global investment management organization that provides a wide array of mutual funds, advisory services, and account management for both individual and institutional investors. While not a biotechnology or pharmaceutical company itself, it is a critical player in the life sciences ecosystem as one of the world's largest institutional investors in the sector. The firm is particularly well-known for its T. Rowe Price Health Sciences Fund, which actively invests in companies involved in the research, development, and distribution of healthcare products and services. For a biotech analyst, T. Rowe Price is significant as a major 'crossover' investor that frequently participates in late-stage private financing rounds and initial public offerings (IPOs) of emerging therapeutic companies. Headquartered in Baltimore, Maryland, the firm operates globally and is recognized for its rigorous fundamental research approach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on T. Rowe Price Group.